Tag: spcs

Showing 24 out of 32 results

08 December 2020

As the Bundestag passes the legislation to ratify the UPC Agreement, the UPC may finally open its doors in 2022

As the Bundestag passes the legislation to ratify the UPC Agreement, the UPC may finally open its doors in 2022
09 July 2020

The CJEU’s decision in Santen confirms a restrictive interpretation of ‘product’ under article 1(b) and 3(d) of the SPC Regulation, and rejects the possibility of an SPC based on a Marketing Authorisation for a new use of a previously authorised product

The CJEU’s decision in Santen confirms a restrictive interpretation of ‘product’ under article 1(b) and 3(d) of the SPC Regulation, and rejects the possibility of an SPC based on a Marketing Authorisation for a new use of a previously authorised product
10 February 2020

Patent and Pharma Update, February 2020

Patent and Pharma Update, February 2020
24 January 2020

CJEU AG's Opinion in Santen referral proposes to abandon Neurim

CJEU AG's Opinion in Santen referral proposes to abandon Neurim
18 September 2019

CJEU refuses UK High Court's request for preliminary ruling on SPC applications based on third-party MAs, on account of referred question being "hypothetical" (C-239/19 Eli Lilly v Genentech)

CJEU refuses UK High Court's request for preliminary ruling on SPC applications based on third-party MAs, on account of referred question being "hypothetical" (C-239/19 Eli Lilly v Genentech)
20 December 2018

Preparations for the UPC continue despite an "unpredictable environment"

The UPC Preparatory Committee has issued a “Status of the Unified Patent Court Project” statement and review of 2018, confirming that there …
14 December 2018

Advocate General proposes literal interpretation of Article 3(d) SPC Regulation in Abraxis (C-443/17)

The Advocate General of the CJEU proposed a narrow interpretation of Article    3(d) in the Opinion given yesterday in Abraxis …
12 December 2018

Patent and Pharma Update - December 2018

Patent and Pharma Update - December 2018
19 November 2018

French court upholds validity of MSD's SPC protecting ezetimibe and simvastatin in combination

A French Court has upheld the validity of a Supplementary Protection Certificate ("SPC") protecting the ezetimibe+simvastatin combination under Article …
15 November 2018

Draft Withdrawal Agreement Approved by UK Cabinet - IP and Marketing Authorisation Provisions Summarised

As was widely reported yesterday evening, the Draft Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the …
25 September 2018

Brexit "no deal" technical notices published on Patents, Trade marks, Designs, Copyright, GIs, and Exhaustion of rights

The latest tranche of "no deal" technical notices was released yesterday afternoon by the UK Government. Amongst them are several notices …
25 July 2018

CJEU SETS OUT TEST ON THE INTERPRETATION OF ARTICLE 3(a) SPC REGULATION

The Court of Justice of the European Union (CJEU) has today delivered its decision on the interpretation of Article 3(a) SPC Regulation in Case C-121/17 …